DNA damage-inducible transcript 4 protein (DDIT4)

DNA damage-inducible transcript 4 protein (DDIT4), also known as RTP801 or REDD1, is a ubiquitously expressed stress-induced protein encoded by the DDIT4 gene. It acts primarily as a negative regulator of the mechanistic target of rapamycin (mTOR) pathway—a key controller of cellular growth, proliferation, metabolism, autophagy, and survival. Upregulated under conditions such as hypoxia or DNA damage through HIF‑1 activation, it inhibits mTOR via activation of TSC1/2 complexes. In neurons specifically, elevated levels contribute to apoptotic cell death by sequentially inhibiting both mTOR and Akt kinases, which has been implicated in several neurodegenerative diseases including Parkinson's disease, Alzheimer's disease, Huntington's disease, as well as certain cancers where dysregulation affects tumorigenesis. Beyond these roles, recent research shows that RTP801 interacts with components involved in RNA processing during endoplasmic reticulum stress responses—further linking it to pathological processes involving misfolded proteins such as those seen in Alzheimer’s models. Its modulation represents a promising therapeutic strategy but requires careful balancing due to its dual roles depending on context—sometimes promoting cell survival under acute stress but driving degeneration when chronically elevated.

Other names

RTP801REDD1Regulated in development and DNA damage response 1HIF-1 responsive protein RTP801FLJ20500

Drugs that modulate the activity or expression of DDIT4/RTP801 generally act by influencing the mTOR signaling pathway—either by upregulating DDIT4 to suppress mTOR activity or indirectly affecting its downstream effects on cell growth, survival, or autophagy.